Concord medical announces its subsidiary's application filing for potential listing on the stock exchange of hong kong limited

Beijing , june 1, 2022 /prnewswire/ -- concord medical services holdings limited ("concord medical" or the "company") (nyse: ccm), a healthcare provider specialized in cancer treatment, research, education and prevention by establishing proton centers and cancer hospitals and operating an extensive network of radiotherapy and diagnostic imaging centers in china, today announced that its subsidiary, concord healthcare group co., ltd. ("concord healthcare"), a company incorporated in china, filed an application (the "application") to list a minority stake of its shares (the "concord healthcare  shares") on the stock exchange of hong kong limited (the "hong kong stock exchange") (the "listing") on may 31, 2022.
CCM Ratings Summary
CCM Quant Ranking